Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive congenital ichthyosis in which the cause of the disease is a mutation in the CASP14 gene.
Features include: White scaling skin.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 1 | White scaling skin |
CASP14 encodes caspase 14 (242 aa). Non-apoptotic caspase involved in epidermal differentiation. Is the predominant caspase in epidermal stratum corneum. Highest expression in Skin Sun Exposed Lower leg (655.0 TPM) and Skin Not Sun Exposed Suprapubic (574.7 TPM).
Ichthyosis, congenital, autosomal recessive 12 is associated with mutations in the CASP14 gene on chromosome 19.
The CASP14 protein participates in Keratinocyte of granulosum layer differentiates into corneocyte of corneum layer in interfollicular epidermis pathway.
CASP14 is classified as a druggable target (Druggable Genome, Enzyme, and Protease categories) with score 4.0.
Genetic testing for CASP14 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for ichthyosis, congenital, autosomal recessive 12 has been reported in the published literature.
No clinical trials have been registered for ichthyosis, congenital, autosomal recessive 12.
14 publications have been identified in PubMed for ichthyosis, congenital, autosomal recessive 12. Research spans Case Report / Case Series (50%), Basic Science / Preclinical (21%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 50% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:51 AM UTC
Online Mendelian Inheritance in Man
Laboratory research
3 |
21% |
Research summaries | 2 | 14% |
Testing and diagnosis research | 1 | 7% |
Disease patterns and progression | 1 | 7% |
Sattar MA (2026). [PMID: 42196615](https://pubmed.ncbi.nlm.nih.gov/42196615/). *Int J Mol Sci*. [Case Report / Case Series]
Elgie T (2026). [PMID: 42001132](https://pubmed.ncbi.nlm.nih.gov/42001132/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Vinberg C (2025). [PMID: 41057024](https://pubmed.ncbi.nlm.nih.gov/41057024/). *Animal genetics*. [Case Report / Case Series]
Caetano DG (2025). [PMID: 41453769](https://pubmed.ncbi.nlm.nih.gov/41453769/). *BMJ case reports*. [Case Report / Case Series]
Sefer AP (2025). [PMID: 41346588](https://pubmed.ncbi.nlm.nih.gov/41346588/). *Frontiers in immunology*. [Basic Science / Preclinical]
Simard-Bisson C (2025). [PMID: 40981344](https://pubmed.ncbi.nlm.nih.gov/40981344/). *Dermatopathology (Basel, Switzerland)*. [Basic Science / Preclinical]
Roche-Gomez A (2025). [PMID: 40471236](https://pubmed.ncbi.nlm.nih.gov/40471236/). *Pediatric nephrology (Berlin, Germany)*. [Case Report / Case Series]
Xiang R (2025). [PMID: 40709761](https://pubmed.ncbi.nlm.nih.gov/40709761/). *Acta Derm Venereol*. [Review / Meta-Analysis]
Thakur K (2024). [PMID: 38514164](https://pubmed.ncbi.nlm.nih.gov/38514164/). *BMJ case reports*. [Case Report / Case Series]
Fioretti T (2024). [PMID: 38791074](https://pubmed.ncbi.nlm.nih.gov/38791074/). *Biomedicines*. [Diagnostic / Biomarker]